Mylan NV (NASDAQ:MYL) has been given a “BBB-” credit rating by Morningstar. The research firm’s “BBB-” rating indicates that the company is a moderate default risk. They also gave their stock a three star … · 11/21/2015
Mylan NV
Shareholders of the drugmaker Perrigo shut the door on a $26-billion hostile takeover bid from Mylan. Mylan acknowledged that its cash-and-stock offer failed to garner enough interest from Perrigo shareholders by a …
New Jersey Online · 11/18/2015
Papa, John Hendrickson, Judy Brown and the Allegan-based leadership team at Perrigo Co. is still at the helm of the company following Mylan NV's unsuccessful attempt at a hostile takeover. The rival drugmaker …
MLive · 11/22/2015
Mylan vs
even after today's pop Mylan's stock is trading for less than 12 times full year estimates. If the company is successful in reaching its 2018 earnings target, then buying a few shares of Mylan even after today's move might prove to be a good decision in ...
The Motley Fool · 11/13/2015
Hostile Takeover
Mylan NV (NASDAQ:MYL)‘s stock had its “overweight” rating reiterated by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Wednesday, reports.
Watch List News · 11/18/2015
Mylan NV
In-depth coverage >
Mylan had offered Perrigo cash of $75 per share and 2.3 shares of Mylan stock for each share of Perrigo, a bid that Perrigo based in Dublin rejected as being inadequate. Perrigo is the maker of both over the counter and … · 11/13/2015
Generic drug maker Mylan NV may lose its protracted hostile takeover bid for peer Perrigo Company Plc. as only a minority of Perrigo’s shareholders reportedly tendered their stock into Mylan’s $26 billion takeover …
International Business Times · 11/13/2015
Takeover Deal
Mylan NV (NASDAQ:MYL) had its target price trimmed by BMO Capital Markets to $46.00 in a research report report published on Monday morning, Analyst Ratings.Net reports. The firm currently has a market perform rating on the stock. Mylan NV …
Intercooler · 11/19/2015
Mylan NV
Perrigo Company plc (PRGO) said shareholders holding over 60% of the company's outstanding shares refused to tender into Mylan's inadequate offer. Perrigo said it will immediately commence the company's previously announced $2 billion repurchase of …
Realtime Business News · 11/13/2015
The worst performing stock in the VIP basket year-to-date, according to the note, has been Yahoo with a -35% return, followed by Cheniere Energy (-29%), American Airlines (-20%), Liberty Global (-10%), and Mylan
Yahoo Finance · 1 day ago
hedge funds


Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands and with operational headquarters …
Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands and with operational headquarters in Hatfield, Hertfordshire in the United Kingdom. In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, Mylan has grown from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world. Mylan now has approximately 30,000 employees, more than 1,000 separate products, and serves customers in more than 150 countries and territories. Mylan has a global manufacturing output of more than 45 billion doses.
Data from: Wikipedia · Freebase